In solid tumors such as melanoma and hepatocellular carcinoma (HCC), SHP2 activity positively correlates with PD-L1 expression, further underscoring its central role in modulating the tumor immune microenvironment [23,24]. Here, PTPN11 is linked to neoplasm.